'Tarlatamab's FDA approval: shaping the future of cancer therapy'
- PMID: 39359806
- PMCID: PMC11444618
- DOI: 10.1097/MS9.0000000000002555
'Tarlatamab's FDA approval: shaping the future of cancer therapy'
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30. - PubMed
-
- CDC . Centers for Disease Control and Prevention Risk Factors for Lung Cancer Centers for Disease Control and Prevention. Accessed July 7, 2024. https://www.cdc.gov/lung-cancer/risk-factors/?CDC_AAref_Val=https://www....
-
- Cleveland Clinic . Small Cell Lung Cancer. Cleveland Clinic website. Accessed 8 July 2024. https://my.clevelandclinic.org/health/diseases/6202-small-cell-lung-cancer
-
- DAILYMED . Medtronic. Mitomycin (mitomycin) - Label Information. DailyMed. Accessed July 7, 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e7b6163-5d83-4...
Publication types
LinkOut - more resources
Full Text Sources